Skip to main content
Patients
About Barostim
Clinical Results
Reimbursement
Resources
MRI Information
Investigator Research
Instructions For Use
Marketing Toolkit
About Us
Our Company
Our Team
Newsroom
Careers
Investors
Go
Healthcare Professionals
Clinical Results
Reimbursement
Resources
MRI Information
Investigator Research
Instructions For Use
Marketing Toolkit
About Us
Our Company
Our Team
Newsroom
Careers
Investors
Overview
News & Events
News Releases
Events
Information
Stock Quote and Chart
Analyst Coverage
Corporate Governance
Documents and Charters
Management Team
Board of Directors
Committee Composition
Financial Information
SEC Filings
Annual Reports
Quarterly Results
IR Resources
FAQs
Email Alerts
Contact IR
For Patients
Contact
Press Release
CLINICALLY RELEVANT AND SUPER RESPONDER RATES ARE SIMILAR TO THOSE SEEN WITH CRT
See the Poster Here: Symptomatic Endpoint Responder Rates to BAROSTIM THERAPY
See the poster
Ready to learn more about Barostim?